Regulation 224 Amendment of regulation 341 (decisions under the Human Medicines Regulations 2012)I1F1
United Kingdom
In regulation 341(4)—
(a)
in paragraph (a), insert “UK” before “marketing authorisation”;
(b)
after paragraph (a), insert—
“(aa)a decision to grant or revoke an EU marketing authorisation;”.
Annotations
Textual amendments
- F1
Reg. 224 substituted (31.12.2020 immediately before IP completion day) by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2020 (S.I. 2020/1488), reg. 1, Sch. 2 para. 184
Commencement
- I1
Reg. 224 in force at 31.12.2020 on IP completion day (in accordance with 2020 c. 1, Sch. 5 para. 1(1)), see reg. 1